ATP5MC3
ATP synthase F(0) complex subunit C3, mitochondrial
Also known as: AT5G3_HUMAN, ATP5G3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48201
- Gene
- ATP5MC3
- Ensembl
- ENSG00000154518
- Chromosome
- 2
- Canonical length
- 142 aa
- Protein class
- Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel seems to have nine subunits (a, b, c, d, e, f, g, F6 and 8). This gene is one of three genes that encode subunit c of the proton channel. Each of the three genes have distinct mitochondrial import sequences but encode the identical mature protein. Alternatively spliced transcript variants encoding different proteins have been identified. [provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
142 residues, UniProt reviewed canonical sequence.
>P48201|ATP5MC3
1 MFACAKLACT PSLIRAGSRV AYRPISASVL SRPEASRTGE GSTVFNGAQN GVSQLIQREF
61 QTSAISRDID TAAKFIGAGA ATVGVAGSGA GIGTVFGSLI IGYARNPSLK QQLFSYAILG
121 FALSEAMGLF CLMVAFLILF AMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP5MC3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 1,149 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 1,149 nTPM
- tongue: 1,015 nTPM
- skeletal muscle: 728 nTPM
- parathyroid gland: 515 nTPM
- kidney: 416 nTPM
- liver: 371 nTPM
Single-cell type
- parietal cells: 3,391 nCPM
- esophageal basal cells: 1,737 nCPM
- esophageal suprabasal cells: 1,722 nCPM
- enteric transient amplifying cells: 1,479 nCPM
- colonocytes: 1,455 nCPM
- enterocytes: 1,330 nCPM
Immune cell
- total PBMC: 439 nTPM
- myeloid DC: 426 nTPM
- intermediate monocyte: 333 nTPM
- plasmacytoid DC: 315 nTPM
- non-classical monocyte: 311 nTPM
- classical monocyte: 295 nTPM
Brain region
- choroid plexus: 141 nTPM
- hypothalamus: 133 nTPM
- cerebellum: 123 nTPM
- pons: 116 nTPM
- medulla oblongata: 109 nTPM
- thalamus: 109 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP5MC3.
Disease | AllUniProt
Conditions ATP5MC3 is implicated in, by any mechanism.
- Dystonia, early-onset, and/or spastic paraplegia (DYTSPG) MIM:619681
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 37 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Dystonia, early-onset, and/or spastic paraplegia
- ATP5G3-associated disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0.26
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP5MC3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP5MC3 as an antibody target. Whether an autoantibody or antibody against ATP5MC3 could matter depends on whether native ATP5MC3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP5MC3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP5MC3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...